Launch Esports, a partnership between two Texas companies, has expanded into more schools. Photo courtesy of Launch

A joint venture between a Houston-based esports tournament software and management company and a Dallas-based college multimedia rights company has expanded into a new market.

Launch Esports, formed by Mainline and Steel Planet Esports, announced a round of competitions that bring structure and continuity to conference-level play for small college conferences and schools across the country, according to a news release.

"Launch Esports and its member conferences are focused on the massive untapped opportunity to reach a community at over 1,500 schools across the nation," says Darin David, president of Launch Esports, in the release. "By bringing the advanced tools, best practices, competition platforms, and live event production to these schools, we are opening a huge opportunity for a collegiate community that reaches 55+ million students and alumni nationwide."

Launch Esports is providing its platform and structure for Division II, Division III, NAIA and community college conferences and universities, including KCAC, Mid-South Conference, Conference Carolinas, Sooner Athletic Conference, and Red River Athletic Conference.

"Our experience with Launch Esports running our Madden Invitational this summer was excellent and has only added to the KCAC's vision of esports as we enter our inaugural year of full competition this fall," said KCAC Commissioner Dr. Scott Crawford. "Launch has delivered on building first-class tournaments for our student-athletes and teams. It is a great feeling to know we are working with the premier partner ensuring a best-in-class experience when it comes to the overall platform, onboarding competitors and teams, marketing competitions, and broadcasting the great competition within the KCAC."

This initiative is just the first expansion for Launch Esports. According to the release, Launch anticipates adding more conferences across various NAIA, Division II, Division III and Community Colleges.

"The Mid-South Conference is proud to partner with Launch Esports as we begin to compete as a conference this fall," says Eric Ward, commissioner of the Mid-South Conference, in the release. "Their knowledge and expertise in competitive gaming will make our initial efforts to sponsor esports as a conference championship seamless and hassle-free."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.